MS is an autoimmune disorder in which the immune system attacks myelin, the protective covering of nerve fibres in the brain ...

The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...

Brenig has launched an early Phase 1 trial to evaluate BT-409, its experimental small molecule therapy, in healthy volunteers ...

Experts in multiple sclerosis discuss the potential introduction of a subcutaneous form of ocrelizumab to the market in late 2024 and how they plan to incorporate it into their treatment algorithms.

Therapeutic monoclonal antibodies (mAbs) are potent new tools for a molecular targeted approach to modify the course of multiple sclerosis (MS). Besides natalizumab, which was approved in 2006, three ...

Immediately after occupational therapy (OT), people with multiple sclerosis may show small improvements in daily functioning and mental health-related quality of life (HR-QoL), but OT may have little ...

Medically reviewed by Brigid Dwyer, MD Key Takeaways Disease-modifying therapies slow down the progression of multiple sclerosis. Beta interferon drugs reduce MS attacks by altering the immune ...

Dr. Carolyn Phillips has developed a therapeutic program for patients that integrates music — specifically, the ukulele — to help with movement and memory.

CombiRx is a randomized clinical trial to determine if the combined use of interferon beta-1a (IFN) and glatiramer acetate (GA) is a measurably better therapy than either agent used individually in ...

Hormone replacement therapy can be a way for women to prevent the inflammation that leads to disease. "There's some bone ...

From baseline to week 12 the adjusted mean difference in Modified Fatigue Impact Scale change was 1.88 and 1.20 for CBT and modafinil, respectively, relative to the combination group. HealthDay News — ...

The biotechnology firm Bionxt Solutions has reported a significant achievement in its Multiple Sclerosis (MS) therapy program. Recent preclinical study results for its novel Cladribine formulation ...